# Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

> **NCT04503460** · PHASE4 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 24 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salmeterol Xinafoate
- **DRUG:** Salmeterol Fluticasone

## Key facts

- **NCT ID:** NCT04503460
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-23
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04503460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04503460, "Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04503460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*